Besides supporting healthcare startups, the partnership will also contribute to India’s aspiration of emerging as a US$300 billion Bio-economy by 2030
Takeda has announced the signing of a three-year MoU with the Biotechnology Industry Research Assistance Council (BIRAC). The MoU was announced in the presence of Dr Jitendra Singh, Union Minister of State for Science & Technology, Minister of State for the Prime Minister Office, Government of India, and senior government and industry leaders. The partnership will allow Takeda to extend advisory and mentoring support to innovators and entrepreneurs while assisting them from ideation to market deployment of new-age healthcare solutions.
Speaking of the collaboration, Sanjay Patel, Global Head of Data Digital and Technology Innovation Capability Solutions, Takeda Pharmaceuticals International AG, said, “India is a vibrant and promising healthcare market. The country’s healthcare segment offers an incredible opportunity both for innovation and growth. The entrepreneurial spirit of domestic healthcare startups has the power to drive healthcare advancements not only in India but globally. This partnership between Takeda and BIRAC, thus, moves beyond convention, signifying a promise to further healthcare in a manner that sets the stage for lasting improvements in the years to come.”
The partnership was announced at the Global Bio-India (GBI) 2023 event organised by the Department of Biotechnology (DBT), Ministry of Science & Technology, Government of India and its Public Sector Undertaking, BIRAC.